Deborah Mortensen

Deborah Mortensen is a seasoned professional in medical writing with extensive experience across various roles in the pharmaceutical industry. Currently serving as the Senior Director of Medical Writing at BridgeBio since August 2023, Mortensen previously held the position of Director of Medical Writing at QED Therapeutics from January 2021 to August 2023. Prior to that, Mortensen was the Associate Director of Medical Writing at Myovant Sciences and the Functional Area Lead for Medical Writing at Genentech, where responsibilities included project management and strategic document oversight for regulatory submissions. Mortensen's career at Genentech began in 1988 and included roles as Principal Medical Writer and Principal Scientific Researcher, contributing to clinical and pre-clinical development efforts. Educational qualifications include a BA in Management from Saint Mary's College of California and an AS in Biological Sciences from Foothill College.